摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1E,6E)-1,7-bis(3,5-di-tert-butyl-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione | 191608-68-1

中文名称
——
中文别名
——
英文名称
(1E,6E)-1,7-bis(3,5-di-tert-butyl-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
英文别名
1,7-Bis(3,5-di-tert-butyl-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione;(1E,6E)-1,7-bis(3,5-ditert-butyl-4-hydroxyphenyl)hepta-1,6-diene-3,5-dione
(1E,6E)-1,7-bis(3,5-di-tert-butyl-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione化学式
CAS
191608-68-1
化学式
C35H48O4
mdl
——
分子量
532.764
InChiKey
FRLWDHDIQCJLBE-WXUKJITCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.9
  • 重原子数:
    39
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.49
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    乙酰丙酮3,5-二叔丁基-4-羟基苯甲醛 在 boron trioxide 、 三仲丁基硼酸酯溶剂黄146正丁胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.08h, 以66%的产率得到(1E,6E)-1,7-bis(3,5-di-tert-butyl-4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
    参考文献:
    名称:
    Non-cytotoxic synthetic analogues of (1E, 6E)-1, 7-Bis (4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-Dione and therapeutic applications thereof in cystic fibrosis
    摘要:
    揭示了一种新颖的合成类似物,即(1E,6E)-1,7-双(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮,以及其在矫正改变的CFTR运输和相关受损氯离子传输中的囊性纤维化疗效应用。在邻位于酚基的位置引入支链烷基基团,产生了具有大幅改善delF508CFTR运输且没有细胞毒性的临床化合物。
    公开号:
    US07521580B1
点击查看最新优质反应信息

文献信息

  • Non-cytotoxic synthetic analogues of (1E, 6E)-1, 7-Bis (4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-Dione and therapeutic applications thereof in cystic fibrosis
    申请人:Sami Labs Ltd.
    公开号:US07521580B1
    公开(公告)日:2009-04-21
    Disclosed are novel, synthetic analogues of (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione and the therapeutic applications for cystic fibrosis thereof in correcting altered CFTR trafficking and the associated impaired chloride (Cl−) ion transport. Introduction of branched-alkyl groups ortho to the phenolic groups gave rise to clinical compounds with vastly improved trafficking of delF508CFTR and with no cytotoxicity.
    揭示了一种新颖的合成类似物,即(1E,6E)-1,7-双(4-羟基-3-甲氧基苯基)-1,6-庚二烯-3,5-二酮,以及其在矫正改变的CFTR运输和相关受损氯离子传输中的囊性纤维化疗效应用。在邻位于酚基的位置引入支链烷基基团,产生了具有大幅改善delF508CFTR运输且没有细胞毒性的临床化合物。
  • [EN] PHENOLIC METAL SALTS AND THEIR PHENOLIC ACIDS AS POLYMER STABILIZERS<br/>[FR] SELS MÉTALLIQUES PHÉNOLIQUES ET LEURS ACIDES PHÉNOLIQUES UTILISÉS COMME STABILISANTS DE POLYMÈRES
    申请人:BASF SE
    公开号:WO2019008002A1
    公开(公告)日:2019-01-10
    The invention relates to a composition comprising a) a polymer and b) (i) a phenolic metal salt of formula (I) Mn+ (L-)n wherein n is 1, 2 or 3, Mn+ is a metal ion and L- is an anion of formula (II) wherein A1 and A2 are both -CH2-CH2-, -CH=CH- or -CH2- or A1 is -CH=CH- and A2 is -CH2- or A1 is -CH2-CH2- and A2 is -CH2-, R1, R2, R4 and R5 are independently from each other C1-C4 alkyl, R3 is H or C1-C4 alkyl, or (ii) a bisphenolic compound of formula (III) wherein A1, A2, and R1 to R5 are as mentioned above, wherein the amount of component b) is from 0.0005 to 0.9 % by weight based on the weight of component a). The phenolic metal salt of formula (I) or the bisphenolic compound of formula (III) stabilizes the polymer against oxidative, thermal or light-induced degradation. Further embodiments are also an additive mixture comprising the phenolic metal salt of formula (I) or the bisphenolic compound of formula (III) and a further additive or a process for adding the component b) to the polymer, for example in an extruder.
    本发明涉及一种组合物,包括a)聚合物和b)(i)式(I)的酚类金属盐Mn+(L)n,其中n为1、2或3,Mn+为金属离子,L-为式(II)的阴离子,其中A1和A2均为-CH2-CH2-,-CH=CH-或-CH2-,或者A1为-CH=CH-,A2为-CH2-或A1为-CH2-CH2-,A2为-CH2-,R1、R2、R4和R5各自独立地为C1-C4烷基,R3为H或C1-C4烷基;或(ii)式(III)的双酚类化合物,其中A1、A2和R1至R5如上所述,其中组分b)的量为组分a)的重量的0.0005至0.9%。式(I)的酚类金属盐或式(III)的双酚类化合物可以使聚合物对氧化、热或光诱导降解具有稳定作用。进一步的实施方式还包括包括式(I)的酚类金属盐或式(III)的双酚类化合物和其他添加剂的混合物,或将组分b)添加到聚合物中的方法,例如在挤出机中。
  • Electron ionization mass spectrometry of curcumin analogues: an olefin metathesis reaction in the fragmentation of radical cations
    作者:Ben L. M. van Baar、Jelle Rozendal、Henk van der Goot
    DOI:10.1002/(sici)1096-9888(199804)33:4<319::aid-jms636>3.0.co;2-u
    日期:1998.4
    The natural compound curcumin, used in cosmetics, traditional medicines and as a spice in food, is known as a multi-factorial anti-inflammatory agent. To study the anti-inflammatory activity of curcumin derivatives, 24 analogues were synthesized and their structures were confirmed by H-1 MMR and electron ionization (EI) mass spectrometry. Most signals in the EI mass spectra can be attributed to commonly known fragmentations, but the formation of ring-substituted 1,2-diphenylethene (stilbene)-type radical cations, observed in the spectra of all compounds investigated and resulting in the base peak for some compounds, requires a peculiar rearrangement. Metastable ion spectra and C-13 labelling studies show that the stilbene-type ions are formed directly from the molecular ions and contain the two original aryl groups and the 1 and 7 carbon atoms of the olefinic system. It is proposed that the formation of stilbene-type ions results from an intramolecular olefin metathesis reaction; this suggestion is supported by semi-empirical (MNDO/PM3) calculations. (C) 1998 John Wiley & Sons, Ltd.
  • COMPOSITIONS AND METHODS FOR DETECTING AMYLOID-BETA-DEGRADING ENZYME ACTIVITY
    申请人:Chen Rita P.-Y.
    公开号:US20130102498A1
    公开(公告)日:2013-04-25
    Novel substrates for detection of activity of amyloid beta degrading enzyme, such as Neprilysin (NEP) and insulin degrading enzyme (IDE), associated with Alzheimer's disease, are provided. A quenched fluorogenic peptide substrate containing the first seven residues of the Aβpeptide plus a C-terminal Cys residue to detect neprilysin activity with a fluorophore attached to the C-terminal Cys and a quencher linked to the N-terminus of the peptide is disclosed. An assay system sensitive to endopeptidase activity of NEP and IDE, but insensitive to other Aβ-degrading enzymes is disclosed. Active compounds are identified by a cell-based assay system for high-throughput screening.
  • US7521580B1
    申请人:——
    公开号:US7521580B1
    公开(公告)日:2009-04-21
查看更多